Ipilimumab vs Ranitidine

## Ipilimumab vs Ranitidine: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Ranitidine**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Ranitidine**: Competitive H2 receptor antagonist.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Ranitidine — 2-3 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Ranitidine — C13H22N4O3S.

**Molecular Weight**: Ipilimumab — N/A; Ranitidine — 314.4050 g/mol.

**Type**: Ipilimumab — Antibody; Ranitidine — Small molecule.